Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotics to Treat HSIL and Reduce Persistent High Risk HPV Infection in Women and Men Living With HIV

NCT06949800 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06949800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06949800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotics to Treat HSIL and Reduce Persistent High Risk HPV Infection in Women and Men Living With HIV
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Recruiting
Start date
September 4, 2026
Completion date
May 31, 2028
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anal hsil, hpv-related squamous cell carcinoma, hsil, high grade squamous intraepithelial lesion